Pulmonx Corporation (LUNG) Tops Q4 EPS by 14c

Pulmonx Corporation (NASDAQ: LUNG) reported Q4 EPS of ($0.25), $0.14 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $22.59 million versus the consensus estimate of $23.21 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Pacific Booker Minerals Inc. Adopts Advance Notice Policy for Director Elections
• MoveSmart Rentals Opens Toronto Branch, Expanding Its Canadian Leasing Operations